• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

    12.67 +0.01 (+0.07%)
    Streaming Delayed Price Updated: 10:57 AM EDT, Aug 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 57,773
    Open 12.41
    Bid (Size) 12.64 (100)
    Ask (Size) 12.70 (200)
    Prev. Close 12.66
    Today's Range 12.27 - 12.83
    52wk Range 9.400 - 53.55
    Shares Outstanding 11,776,542
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline ↗
    Tonix Pharmaceuticals (NASDAQ:TNXP) is focusing its near-term strategy on the commercial launch of TONMYA for fibromyalgia while advancing development programs in Lyme disease prevention and major... 
    Via MarketBeat
    News headline image
    Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript ↗
    TONMYA sales hit $11 million in its second quarter on market. 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    -23.4%
    -23.4%
    1 Month
    +15.4%
    +15.4%
    3 Month
    -11.2%
    -11.2%
    6 Month
    -16.9%
    -16.9%
    1 Year
    -68.4%
    -68.4%

    More News

    Read More
    News headline image
    Tonix Pharmaceuticals Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Tonix Pharmaceuticals (NASDAQ:TNXP) Beats Revenue Estimates in First Full Quarter of TONMYA Sales ↗
    Via Chartmill
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
    Via Investor Brand Network
    NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in August, September Investor Conferences
    Via Investor Brand Network
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Receives FDA Feedback for Lyme Disease Prevention Study
    Via Investor Brand Network
    MissionIRNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Schedules Second-Quarter 2026 Results Call for Aug. 10
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Mpox Research Supporting TNX-801 Vaccine Development
    Via Investor Brand Network
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands TONMYA Medicare Coverage to 145 Million Lives
    Via Investor Brand Network
    NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Enrolls First Patient in Phase 2 Depression Trial
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in BTIG Infectious Disease Day 2026
    Via Investor Brand Network
    MissionIRNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands TONMYA Coverage to 52 Million Commercial Lives
    Via Investor Brand Network
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Real-World Data Highlighting Widespread Opioid Use Among Fibromyalgia Patients
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Phase 1 TNX-1500 Data Supporting Advancement into Phase 2
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Real-World Fibromyalgia Burden Data at ISPOR 2026
    Via Investor Brand Network
    TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Fibromyalgia Real-World Data at ISPOR 2026
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in Two May Investor Conferences
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q1 2026 Results, Highlights TONMYA Commercial Growth and Pipeline Progress
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Secures GPO Agreement Covering 35 Million Lives for TONMYA
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data and Plans Phase 2 Study for Lyme Disease Prevention Candidate
    Via Investor Brand Network
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Highlights Preclinical Immuno-Oncology Data At AACR 2026
    Via Investor Brand Network
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Publication of TONMYA Pharmacokinetic Study in Peer-Reviewed Journal
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study
    Via Investor Brand Network

    Frequently Asked Questions

    Is Tonix Pharmaceuticals Holding Corp. - Common Stock publicly traded?
    Yes, Tonix Pharmaceuticals Holding Corp. - Common Stock is publicly traded.
    What exchange does Tonix Pharmaceuticals Holding Corp. - Common Stock trade on?
    Tonix Pharmaceuticals Holding Corp. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock?
    The ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock is TNXP on the Nasdaq Stock Market
    What is the current price of Tonix Pharmaceuticals Holding Corp. - Common Stock?
    The current price of Tonix Pharmaceuticals Holding Corp. - Common Stock is 12.67
    When was Tonix Pharmaceuticals Holding Corp. - Common Stock last traded?
    The last trade of Tonix Pharmaceuticals Holding Corp. - Common Stock was at 08/18/26 10:57 AM ET
    What is the market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock?
    The market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock is 149.20M
    How many shares of Tonix Pharmaceuticals Holding Corp. - Common Stock are outstanding?
    Tonix Pharmaceuticals Holding Corp. - Common Stock has 149M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.